Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.51 |
| ▸ | CA2 | P00918 | 3/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | HTR1D | P28221 | 5/20 | 0.45 |
| ▸ | HTR1A | P08908 | 4/20 | 0.45 |
| ▸ | HTR1B | P28222 | 4/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13933202 | 0.96 | CA1 (0.49) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL598333 | 0.96 | CA1 (0.50) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL1713420 | 0.92 | CA1 (0.61) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL14506101 | 0.92 | HSD11B1 (0.47) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL29839512 | 0.92 | CA1 (0.61) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL6808615 | 0.90 | HSD11B1 (0.46) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL8499219 | 0.90 | L3MBTL1 (0.50) | CA1CA2HSD11B1LMNAHTT | |
| SCHEMBL4557839 | 0.90 | CA1 (0.55) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL24215026 | 0.89 | HSD11B1 (0.45) | CA1CA2HSD11B1CA9HTR1D | |
| SCHEMBL1889520 | 0.89 | HSD11B1 (0.48) | CA1CA2HSD11B1CA9HTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017005824-A1 | ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-01-12 | — | — | WO | disclosed |
| EP-3115433-A1 | ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-01-11 | — | — | EP | disclosed |
| US-8241762-B2 | Charge transport materials for luminescent applications | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-08-14 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-20080297040-A1 | CHARGE TRANSPORT MATERIALS FOR LUMINESCENT APPLICATIONS | LG CHEM, LTD. (KR) | 2008-12-04 | — | — | US | disclosed |
| US-7285341-B2 | Complex fluorene-containing compounds for use in OLED devices | EASTMAN KODAK COMPANY (US) | 2007-10-23 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080297040-A1 | CHARGE TRANSPORT MATERIALS FOR LUMINESCENT APPLICATIONS | TRMT1L, LCLAT1, MCOLN1 | CA1 3115/4885CA2 1779/4885HSD11B1 3322/4885 |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | CA1 1984/4885CA2 3704/4885HSD11B1 2532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.